BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22377519)

  • 1. An example of designed multiple ligands spanning protein classes: dual MCH-1R antagonists/DPPIV inhibitors.
    Gattrell WT; Sambrook Smith CP; Smith AJ
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2464-9. PubMed ID: 22377519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel phenethylpyridone derivatives as potent melanin-concentrating hormone 1 receptor antagonists.
    Ando M; Sekino E; Haga Y; Moriya M; Ito M; Ito J; Iwaasa H; Ishihara A; Kanatani A; Ohtake N
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5186-90. PubMed ID: 19632840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries.
    Matheeussen V; Baerts L; De Meyer G; De Keulenaer G; Van der Veken P; Augustyns K; Dubois V; Scharpé S; De Meester I
    Biol Chem; 2011 Mar; 392(3):189-98. PubMed ID: 21194356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl peptidase 8/9-like activity in human leukocytes.
    Maes MB; Dubois V; Brandt I; Lambeir AM; Van der Veken P; Augustyns K; Cheng JD; Chen X; Scharpé S; De Meester I
    J Leukoc Biol; 2007 May; 81(5):1252-7. PubMed ID: 17287297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
    Yazbeck R; Howarth GS; Abbott CA
    Trends Pharmacol Sci; 2009 Nov; 30(11):600-7. PubMed ID: 19837468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship studies on isoindoline inhibitors of dipeptidyl peptidases 8 and 9 (DPP8, DPP9): is DPP8-selectivity an attainable goal?
    Van Goethem S; Matheeussen V; Joossens J; Lambeir AM; Chen X; De Meester I; Haemers A; Augustyns K; Van der Veken P
    J Med Chem; 2011 Aug; 54(16):5737-46. PubMed ID: 21711053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking-based 3D-QSAR study for selectivity of DPP4, DPP8, and DPP9 inhibitors.
    Kang NS; Ahn JH; Kim SS; Chae CH; Yoo SE
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3716-21. PubMed ID: 17462890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: a new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554.
    Banno Y; Miyamoto Y; Sasaki M; Oi S; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Tsubotani S; Tani A; Funami M; Tawada M; Yamamoto Y; Aertgeerts K; Yano J; Maezaki H
    Bioorg Med Chem; 2011 Aug; 19(16):4953-70. PubMed ID: 21764322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9.
    Zhang H; Chen Y; Keane FM; Gorrell MD
    Mol Cancer Res; 2013 Dec; 11(12):1487-96. PubMed ID: 24038034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: identification of dipeptide derived leads.
    Van der Veken P; De Meester I; Dubois V; Soroka A; Van Goethem S; Maes MB; Brandt I; Lambeir AM; Chen X; Haemers A; Scharpé S; Augustyns K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4154-8. PubMed ID: 18556199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting obesity with a sugar-based library: discovery of novel MCH-1R antagonists by a new computational-VAST approach for exploration of GPCR binding sites.
    Heifetz A; Barker O; Verquin G; Wimmer N; Meutermans W; Pal S; Law RJ; Whittaker M
    J Chem Inf Model; 2013 May; 53(5):1084-99. PubMed ID: 23590178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: isoindoline containing inhibitors.
    Van Goethem S; Van der Veken P; Dubois V; Soroka A; Lambeir AM; Chen X; Haemers A; Scharpé S; De Meester I; Augustyns K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4159-62. PubMed ID: 18556198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of a propeller loop in the quaternary structure and enzymatic activity of prolyl dipeptidases DPP-IV and DPP9.
    Tang HK; Chen KC; Liou GG; Cheng SC; Chien CH; Tang HY; Huang LH; Chang HP; Chou CY; Chen X
    FEBS Lett; 2011 Nov; 585(21):3409-14. PubMed ID: 22001206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.
    Lankas GR; Leiting B; Roy RS; Eiermann GJ; Beconi MG; Biftu T; Chan CC; Edmondson S; Feeney WP; He H; Ippolito DE; Kim D; Lyons KA; Ok HO; Patel RA; Petrov AN; Pryor KA; Qian X; Reigle L; Woods A; Wu JK; Zaller D; Zhang X; Zhu L; Weber AE; Thornberry NA
    Diabetes; 2005 Oct; 54(10):2988-94. PubMed ID: 16186403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel series of substituted biphenylmethyl urea derivatives as MCH-R1 antagonists for the treatment of obesity.
    Galiano S; Ceras J; Cirauqui N; Pérez S; Juanenea L; Rivera G; Aldana I; Monge A
    Bioorg Med Chem; 2007 Jun; 15(11):3896-911. PubMed ID: 17407817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SUMO1-E67 interacting loop peptide is an allosteric inhibitor of the dipeptidyl peptidases 8 and 9.
    Pilla E; Kilisch M; Lenz C; Urlaub H; Geiss-Friedlander R
    J Biol Chem; 2013 Nov; 288(45):32787-32796. PubMed ID: 24072711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of dipeptidyl peptidase 8/9 impairs preadipocyte differentiation.
    Han R; Wang X; Bachovchin W; Zukowska Z; Osborn JW
    Sci Rep; 2015 Aug; 5():12348. PubMed ID: 26242871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors.
    Wallace MB; Feng J; Zhang Z; Skene RJ; Shi L; Caster CL; Kassel DB; Xu R; Gwaltney SL
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2362-7. PubMed ID: 18346892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.
    Ji X; Su M; Wang J; Deng G; Deng S; Li Z; Tang C; Li J; Li J; Zhao L; Jiang H; Liu H
    Eur J Med Chem; 2014 Mar; 75():111-22. PubMed ID: 24531224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, SAR, and atropisomerism of imidazolopyrimidine DPP4 inhibitors.
    O'Connor SP; Wang Y; Simpkins LM; Brigance RP; Meng W; Wang A; Kirby MS; Weigelt CA; Hamann LG
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6273-6. PubMed ID: 20833042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.